SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nutrafuels Inc – ‘10-12G’ on 11/1/17 – ‘EX-3.4’

On:  Wednesday, 11/1/17, at 4:59pm ET   ·   Accession #:  1511164-17-629   ·   File #:  0-55144

Previous ‘10-12G’:  None   ·   Next:  ‘10-12G/A’ on 12/4/17   ·   Latest:  ‘10-12G/A’ on 2/22/18   ·   17 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/01/17  Nutrafuels Inc                    10-12G                30:7.1M                                   Printing & Proxy, LLC/FA

Registration of Securities (General Form)   —   Form 10
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-12G      Registration of Securities (General Form)           HTML    436K 
 2: EX-3.1      Articles of Organization of Nutrafuels, LLC, A      HTML     11K 
                          Florida Limited Liability Company                      
 3: EX-3.2      Certificate of Conversion From A Florida Limited    HTML     11K 
                          Liability Company to A Florida                         
                          Corporation                                            
 4: EX-3.3      Articles of Incorporation of Nutrafuels, Inc., A    HTML     11K 
                          Florida Corporation                                    
 5: EX-3.4      Certificate of Designation of Series A Preferred    HTML     20K 
                          Shares                                                 
 6: EX-3.5      Bylaws of Nutrafuels, Inc                           HTML     48K 
 7: EX-99.1     Employment Agreement With Edgar Ward, Dated         HTML     41K 
                          October 10, 2017                                       
16: EX-99.10    Agreement With Michael R. Anderson, Dated April     HTML     66K 
                          10, 2017                                               
17: EX-99.11    Agreement With Kenneth Duchin, Dated February 23,   HTML     16K 
                          2017                                                   
18: EX-99.12    Agreement With Cfn Media, Dated December 5, 2016    HTML     39K 
19: EX-99.13    Agreement With Nicole Archon                        HTML     14K 
20: EX-99.14    Agreement With Venture Capital Group LLC, Dated     HTML     47K 
                          December 14, 2016                                      
21: EX-99.15    Agreement With Sylvan Eudes                         HTML     14K 
22: EX-99.16    Agreement With Peter Ciarci, Dated August 1, 2015   HTML     48K 
23: EX-99.17    Agreement With Fivestar Labs LLC, Dated August 1,   HTML     52K 
                          2015                                                   
24: EX-99.18    Agreement With Osprey Capital Advisors, Dated       HTML     57K 
                          October 1, 2015                                        
25: EX-99.19    Agreement With Wt Consulting, Dated July 18, 2015   HTML     55K 
 8: EX-99.2     Agreement With Neil Catania Dated October 9, 2017   HTML     14K 
26: EX-99.20    Agreement With Uptick Capital, Dated October 14,    HTML     30K 
                          2014                                                   
27: EX-99.21    Agreement With Benchmark Advisory Partners LLC,     HTML     51K 
                          Dated April 14, 2015                                   
28: EX-99.22    Agreement With Sullivan Media, Dated August 25,     HTML     15K 
                          2015                                                   
29: EX-99.23    Neil Catania Note Agreement in the Amount of        HTML     21K 
                          $160,000                                               
30: EX-99.24    Neil Catania Note Agreement in the Amount of        HTML     21K 
                          $50,000                                                
 9: EX-99.3     Agreement With Jz Marketing and Josh Zwagil, Dated  HTML     49K 
                          August 16, 2017                                        
10: EX-99.4     Form of Purchase Order                              HTML     19K 
11: EX-99.5     Agreement With Patagonia Global Trading and David   HTML     51K 
                          Zirulnikoff, Dated December 7, 2015                    
12: EX-99.6     Agreement With Bernadette Cawley                    HTML     14K 
13: EX-99.7     Agreement With Anthony Procelli                     HTML     14K 
14: EX-99.8     Agreement With Patrick Kilcooley                    HTML     14K 
15: EX-99.9     Agreement With Daniel Ryan                          HTML     14K 


EX-3.4   —   Certificate of Designation of Series A Preferred Shares


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <! 
  Converted by EDGARwiz  
 <>   <> 

EX-3.4 5 nutrafuels_ex34.htm CERTIFICATE OF DESIGNATION

EXHIBIT 3.4

 

CERTIFICATE OF DESIGNATION

OF

SERIES A PREFERRED STOCK

OF

NUTRAFUELS, INC.


NutraFuels, Inc., a Florida corporation (the Company), hereby certifies that the following resolution was adopted by the Board of Directors of the Company:

 

RESOLVED, that pursuant to the authority expressly granted to and vested in the Board of Directors of the Company (the Board of Directors) by the provisions of the Articles of Incorporation of the Company (the Articles of Incorporation), there is hereby created, out of the 10,000 shares of preferred stock, par value $.001 per share, of the Company authorized in Article IV of the Articles of Incorporation (the Preferred Stock), a series of preferred stock consisting of 1000 shares, which series shall have the following powers, designations, preferences and relative, participating, optional or other rights, and the following qualifications, limitations and restrictions, (in addition to any powers, designations, preferences and relative, participating, optional or other rights, and any qualification, limitations and restrictions, set forth in the Articles of Incorporation which are applicable to the Preferred Stock):

 

Section 1. Designation of Amount.

 

The series of Preferred Stock created hereby shall be designated the Class A Preferred Stock) and the authorized number of shares constituting such series shall be 1000.


Section 2.  Dividends.

 

The holders of the then outstanding shares of Series A Preferred Stock will not be entitled to receive any dividends that may be granted by the Company.

 

Section 3. Liquidation Preference.

 

In the event of a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (a Liquidation), the holders of the Series A Preferred Stock then outstanding shall not be entitled to receive any distribution out of the assets of the Company as a result of their ownership of the Series A Preferred Stock.

 

Section 4. Voting Rights.

 

(a)               The holders of the Series A Preferred Stock shall have the following voting rights:

 

 

(i)

To vote together with the holders of the Common Stock as a single class on all matters submitted for a vote of holders of Common Stock;

 

 

(ii)

Each share of Series A Preferred Stock shall have voting rights equal to 500,000 shares of the Companys Common Stock, providing for the holder of the Series A Preferred Stock to have the voting right of 500,000,000 shares of the Companys Common Stock;

 

 

1


 




 

 

(iii)

The holder of the Series A Preferred Stock shall be entitled to received notice of any stockholders meeting in accordance with the Articles of Incorporation and By-laws of the Company.

 

For purposes of the voting rights set forth in this Section 4, each one (1) share of Series A Preferred Stock shall entitle the holder thereof to cast 500,000 votes for each whole vote that such holder would be entitled to cast had such share been a share of Common Stock immediately prior to the record date for determining the stockholders of the Company eligible to vote on any such matter.

 

(b)               So long as any shares of Series A Preferred Stock remain outstanding, the Company shall not, without the written consent or affirmative vote of the holders of 100% of the outstanding shares of the Series A Preferred Stock, (i) amend, alter, waive or repeal, whether by merger consolidation, combination, reclassification or otherwise, the Articles of Incorporation, including this Certificate of Designation, or By-laws of the Company or any provisions thereof (including the adoption of a new provision thereof), (ii) create, authorize or issue any class, series or shares of Preferred Stock or any other class of capital stock. The vote of the holders of at least one-hundred percent of the outstanding Series A Stock, voting separately as one class, shall be necessary to adopt any alteration, amendment or repeal of any provisions of this Resolution, in addition to any other vote of stockholders required by law.

 

Section 5. Conversion Rights.


The Series A Preferred Stock will not be convertible into shares of Common Stock or any other shares of the Company.

 

Section 6. Holder, Non-Transferable, Redemption.

 

1,000 shares of the Series A Preferred Stock is hereby granted to Edgar Ward (the Holder). The Company shall redeem the Series A Preferred Stock in whole, but not in part, at the option of the Holder, for $1,000.

 

 

 2


 




 C: 

17 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/21/22  Nutralife Biosciences, Inc.       10-Q        9/30/22   61:4.5M                                   M2 Compliance LLC/FA
 8/22/22  Nutralife Biosciences, Inc.       10-Q        6/30/22   62:4.8M                                   M2 Compliance LLC/FA
 5/23/22  Nutralife Biosciences, Inc.       10-Q        3/31/22   57:3.7M                                   M2 Compliance LLC/FA
 4/11/22  Nutralife Biosciences, Inc.       10-K       12/31/21   72:5.8M                                   M2 Compliance LLC/FA
11/15/21  Nutralife Biosciences, Inc.       10-Q        9/30/21   54:4M                                     M2 Compliance LLC/FA
10/12/21  Nutralife Biosciences, Inc.       10-Q/A      6/30/21    3:75K                                    M2 Compliance LLC/FA
 8/16/21  Nutralife Biosciences, Inc.       10-Q        6/30/21   54:3.8M                                   M2 Compliance LLC/FA
 7/16/21  Nutralife Biosciences, Inc.       10-Q        3/31/21   53:2.7M                                   M2 Compliance LLC/FA
 6/24/21  Nutralife Biosciences, Inc.       10-K       12/31/20   72:4.4M                                   M2 Compliance LLC/FA
 5/12/21  Nutralife Biosciences, Inc.       10-Q        9/30/20   56:2.9M                                   M2 Compliance LLC/FA
 4/22/21  Nutralife Biosciences, Inc.       10-Q        6/30/20   55:2.5M                                   M2 Compliance LLC/FA
 4/12/21  Nutralife Biosciences, Inc.       10-Q        3/31/20   52:2.1M                                   M2 Compliance LLC/FA
 3/19/21  Nutralife Biosciences, Inc.       10-K       12/31/19  132:102M                                   M2 Compliance LLC/FA
 3/13/18  SEC                               UPLOAD4/09/18    1:35K  Nutralife Biosciences, Inc.
 1/05/18  SEC                               UPLOAD4/09/18    1:136K Nutralife Biosciences, Inc.
12/13/17  SEC                               UPLOAD4/09/18    1:140K Nutralife Biosciences, Inc.
11/28/17  SEC                               UPLOAD4/09/18    1:150K Nutralife Biosciences, Inc.
Top
Filing Submission 0001511164-17-000629   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 7:36:01.2pm ET